Literature DB >> 33323480

Functional electrical stimulation in-bed cycle ergometry in mechanically ventilated patients: a multicentre randomised controlled trial.

Dale M Needham1,2,3, Linda Denehy4,5, Sue Berney6,7, Ramona O Hopkins8,9,10, Joleen Wyn Rose7, Rene Koopman11, Zudin Puthucheary12,13, Amy Pastva14, Ian Gordon15, Elizabeth Colantuoni1,16, Selina M Parry17.   

Abstract

PURPOSE: To investigate the effect of functional electrical stimulation-assisted cycle ergometry (FES-cycling) on muscle strength, cognitive impairment and related outcomes.
METHODS: Mechanically ventilated patients aged ≥18 years with sepsis or systemic inflammatory response syndrome were randomised to either 60 min of FES-cycling >5 days/week while in the intensive care unit (ICU) plus usual care rehabilitation versus usual care rehabilitation alone, with evaluation of two primary outcomes: (1) muscle strength at hospital discharge and (2) cognitive impairment at 6-month follow-up.
RESULTS: We enrolled 162 participants, across four study sites experienced in ICU rehabilitation in Australia and the USA, to FES-cycling (n=80; mean age±SD 59±15) versus control (n=82; 56±14). Intervention participants received a median (IQR) of 5 (3-9) FES-cycling sessions with duration of 56 (34-63) min/day plus 15 (10-23) min/day of usual care rehabilitation. The control group received 15 (8-15) min/day of usual care rehabilitation. In the intervention versus control group, there was no significant differences for muscle strength at hospital discharge (mean difference (95% CI) 3.3 (-5.0 to 12.1) Nm), prevalence of cognitive impairment at 6 months (OR 1.1 (95% CI 0.30 to 3.8)) or secondary outcomes measured in-hospital and at 6 and 12 months follow-up.
CONCLUSION: In this randomised controlled trial, undertaken at four centres with established rehabilitation programmes, the addition of FES-cycling to usual care rehabilitation did not substantially increase muscle strength at hospital discharge. At 6 months, the incidence of cognitive impairment was almost identical between groups, but potential benefit or harm of the intervention on cognition cannot be excluded due to imprecision of the estimated effect. TRIAL REGISTRATION NUMBER: ACTRN 12612000528853, NCT02214823. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  critical care; exercise

Mesh:

Year:  2020        PMID: 33323480     DOI: 10.1136/thoraxjnl-2020-215093

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  Therapeutic Potential of Electromyostimulation (EMS) in Critically Ill Patients-A Systematic Review.

Authors:  Maryam Balke; Marc Teschler; Hendrik Schäfer; Pantea Pape; Frank C Mooren; Boris Schmitz
Journal:  Front Physiol       Date:  2022-05-09       Impact factor: 4.755

2.  The sit-to-stand test as a patient-centered functional outcome for critical care research: a pooled analysis of five international rehabilitation studies.

Authors:  Heather K O'Grady; Lara Edbrooke; Christopher Farley; Sue Berney; Linda Denehy; Zudin Puthucheary; Michelle E Kho
Journal:  Crit Care       Date:  2022-06-13       Impact factor: 19.334

Review 3.  Attenuating Muscle Mass Loss in Critical Illness: the Role of Nutrition and Exercise.

Authors:  Lee-Anne S Chapple; Selina M Parry; Stefan J Schaller
Journal:  Curr Osteoporos Rep       Date:  2022-08-31       Impact factor: 5.163

4.  Functional electrical stimulation-assisted cycle ergometry-based progressive mobility programme for mechanically ventilated patients: randomised controlled trial with 6 months follow-up.

Authors:  Petr Waldauf; Natália Hrušková; Barbora Blahutova; Jan Gojda; Tomáš Urban; Adéla Krajčová; Michal Fric; Kateřina Jiroutková; Kamila Řasová; František Duška
Journal:  Thorax       Date:  2021-04-30       Impact factor: 9.139

5.  Bedside voluntary and evoked forces evaluation in intensive care unit patients, not only force evaluation: a letter to the Editor.

Authors:  Paulo Eugênio Silva; João Luiz Quaglioti Durigan; Nicolas Babault
Journal:  Crit Care       Date:  2021-07-01       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.